Handelsbanken Fonder’s Emergent Biosolutions EBS Stock Holding History

Handelsbanken Fonder’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,009	Closed	-$280K	–	1571
2022 Q2	$280K	Hold	9,009	–	–	﹤0.01%	1364
2022 Q1	$370K	Hold	9,009	–	–	﹤0.01%	1399
2021 Q4	$392K	Hold	9,009	–	–	﹤0.01%	1503
2021 Q3	$451K	Hold	9,009	–	–	﹤0.01%	1421
2021 Q2	$567K	Buy	9,009 +1,300	+17%	+$83.5K	﹤0.01%	1288
2021 Q1	$716K	Hold	7,709	–	–	﹤0.01%	1008
2020 Q4	$691K	Hold	7,709	–	–	﹤0.01%	984
2020 Q3	$797K	Hold	7,709	–	–	0.01%	801
2020 Q2	$610K	Buy	+7,709	New	+$574K	0.01%	874

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Handelsbanken Fonder's EBS Position: Q3 2022 in Review

Handelsbanken Fonder sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 9,009 shares — an estimated $280K sold.

Handelsbanken Fonder first reported a position in EBS in Q2 2020 and held it in 9 quarters. The position peaked at $797K in Q3 2020. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

Handelsbanken Fonder reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
Handelsbanken Fonder sold 9,009 Emergent Biosolutions shares in Q3 2022, an estimated $280K.
Handelsbanken Fonder first reported a position in Emergent Biosolutions in Q2 2020 and held it in 9 quarters.
Handelsbanken Fonder's Emergent Biosolutions position peaked at $797K in Q3 2020.
211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Handelsbanken Fonder's 13F filing for Q3 2022, filed 27 Oct 2022.